United States Pneumococcal Infections Vaccine Market Report 2016
![](/report_cover/6975/united-states-pneumococcal-infections-vaccine-market-report-2016_q_en.gif)
Notes:
Sales, means the sales volume of Pneumococcal Infections Vaccine
Revenue, means the sales value of Pneumococcal Infections Vaccine
This report studies sales (consumption) of Pneumococcal Infections Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sales, means the sales volume of Pneumococcal Infections Vaccine
Revenue, means the sales value of Pneumococcal Infections Vaccine
This report studies sales (consumption) of Pneumococcal Infections Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
- Sanofi-Pasteur
- Merck
- Pfizer
- Chengdu Institute of Biological Products
- Type I
- Type II
- Type III
- Application 1
- Application 2
- Application 3
United States Pneumococcal Infections Vaccine Market Report 2016
1 PNEUMOCOCCAL INFECTIONS VACCINE OVERVIEW
1.1 Product Overview and Scope of Pneumococcal Infections Vaccine
1.2 Classification of Pneumococcal Infections Vaccine
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Pneumococcal Infections Vaccine
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pneumococcal Infections Vaccine (2011-2021)
1.4.1 United States Pneumococcal Infections Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Pneumococcal Infections Vaccine Revenue and Growth Rate (2011-2021)
2 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE COMPETITION BY MANUFACTURERS
2.1 United States Pneumococcal Infections Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pneumococcal Infections Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pneumococcal Infections Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Pneumococcal Infections Vaccine Market Competitive Situation and Trends
2.4.1 Pneumococcal Infections Vaccine Market Concentration Rate
2.4.2 Pneumococcal Infections Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)
3.1 United States Pneumococcal Infections Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Pneumococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Pneumococcal Infections Vaccine Price by Type (2011-2016)
3.4 United States Pneumococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)
4 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)
4.1 United States Pneumococcal Infections Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE MANUFACTURERS PROFILES/ANALYSIS
5.1 Sanofi-Pasteur
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Sanofi-Pasteur Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck
5.2.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Pfizer
5.3.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Pfizer Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Chengdu Institute of Biological Products
5.4.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
6 PNEUMOCOCCAL INFECTIONS VACCINE MANUFACTURING COST ANALYSIS
6.1 Pneumococcal Infections Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pneumococcal Infections Vaccine
7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
7.1 Pneumococcal Infections Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pneumococcal Infections Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 MARKET EFFECT FACTORS ANALYSIS
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE MARKET FORECAST (2016-2021)
10.1 United States Pneumococcal Infections Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Pneumococcal Infections Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Pneumococcal Infections Vaccine Sales Forecast by Application (2016-2021)
10.4 Pneumococcal Infections Vaccine Price Forecast (2016-2021)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
Disclosure Section
Research Methodology
Data Source
Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 PNEUMOCOCCAL INFECTIONS VACCINE OVERVIEW
1.1 Product Overview and Scope of Pneumococcal Infections Vaccine
1.2 Classification of Pneumococcal Infections Vaccine
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Pneumococcal Infections Vaccine
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pneumococcal Infections Vaccine (2011-2021)
1.4.1 United States Pneumococcal Infections Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Pneumococcal Infections Vaccine Revenue and Growth Rate (2011-2021)
2 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE COMPETITION BY MANUFACTURERS
2.1 United States Pneumococcal Infections Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pneumococcal Infections Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pneumococcal Infections Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Pneumococcal Infections Vaccine Market Competitive Situation and Trends
2.4.1 Pneumococcal Infections Vaccine Market Concentration Rate
2.4.2 Pneumococcal Infections Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)
3.1 United States Pneumococcal Infections Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Pneumococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Pneumococcal Infections Vaccine Price by Type (2011-2016)
3.4 United States Pneumococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)
4 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)
4.1 United States Pneumococcal Infections Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE MANUFACTURERS PROFILES/ANALYSIS
5.1 Sanofi-Pasteur
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Sanofi-Pasteur Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck
5.2.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Pfizer
5.3.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Pfizer Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Chengdu Institute of Biological Products
5.4.2 Pneumococcal Infections Vaccine Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
6 PNEUMOCOCCAL INFECTIONS VACCINE MANUFACTURING COST ANALYSIS
6.1 Pneumococcal Infections Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pneumococcal Infections Vaccine
7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
7.1 Pneumococcal Infections Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pneumococcal Infections Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 MARKET EFFECT FACTORS ANALYSIS
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 UNITED STATES PNEUMOCOCCAL INFECTIONS VACCINE MARKET FORECAST (2016-2021)
10.1 United States Pneumococcal Infections Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Pneumococcal Infections Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Pneumococcal Infections Vaccine Sales Forecast by Application (2016-2021)
10.4 Pneumococcal Infections Vaccine Price Forecast (2016-2021)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
Disclosure Section
Research Methodology
Data Source
Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Picture of Pneumococcal Infections Vaccine
Table Classification of Pneumococcal Infections Vaccine
Figure United States Sales Market Share of Pneumococcal Infections Vaccine by Type in 2015
Table Application of Pneumococcal Infections Vaccine
Figure United States Sales Market Share of Pneumococcal Infections Vaccine by Application in 2015
Figure United States Pneumococcal Infections Vaccine Sales and Growth Rate (2011-2021)
Figure United States Pneumococcal Infections Vaccine Revenue and Growth Rate (2011-2021)
Table United States Pneumococcal Infections Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Pneumococcal Infections Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pneumococcal Infections Vaccine Sales Share by Manufacturers
Figure 2016 Pneumococcal Infections Vaccine Sales Share by Manufacturers
Table United States Pneumococcal Infections Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers
Table 2016 United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers
Table United States Market Pneumococcal Infections Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pneumococcal Infections Vaccine Average Price of Key Manufacturers in 2015
Figure Pneumococcal Infections Vaccine Market Share of Top 3 Manufacturers
Figure Pneumococcal Infections Vaccine Market Share of Top 5 Manufacturers
Table United States Pneumococcal Infections Vaccine Sales by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales Share by Type (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Market Share by Type in 2015
Table United States Pneumococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pneumococcal Infections Vaccine by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Price by Type (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales by Application (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales Market Share by Application (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Market Share by Application in 2015
Table United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Pasteur Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Chengdu Institute of Biological Products Basic Information List
Table Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Infections Vaccine
Figure Manufacturing Process Analysis of Pneumococcal Infections Vaccine
Figure Pneumococcal Infections Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Infections Vaccine Major Manufacturers in 2015
Table Major Buyers of Pneumococcal Infections Vaccine
Table Distributors/Traders List
Figure United States Pneumococcal Infections Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Pneumococcal Infections Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Pneumococcal Infections Vaccine Production Forecast by Type (2016-2021)
Table United States Pneumococcal Infections Vaccine Consumption Forecast by Application (2016-2021)
Figure Picture of Pneumococcal Infections Vaccine
Table Classification of Pneumococcal Infections Vaccine
Figure United States Sales Market Share of Pneumococcal Infections Vaccine by Type in 2015
Table Application of Pneumococcal Infections Vaccine
Figure United States Sales Market Share of Pneumococcal Infections Vaccine by Application in 2015
Figure United States Pneumococcal Infections Vaccine Sales and Growth Rate (2011-2021)
Figure United States Pneumococcal Infections Vaccine Revenue and Growth Rate (2011-2021)
Table United States Pneumococcal Infections Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Pneumococcal Infections Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pneumococcal Infections Vaccine Sales Share by Manufacturers
Figure 2016 Pneumococcal Infections Vaccine Sales Share by Manufacturers
Table United States Pneumococcal Infections Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers
Table 2016 United States Pneumococcal Infections Vaccine Revenue Share by Manufacturers
Table United States Market Pneumococcal Infections Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pneumococcal Infections Vaccine Average Price of Key Manufacturers in 2015
Figure Pneumococcal Infections Vaccine Market Share of Top 3 Manufacturers
Figure Pneumococcal Infections Vaccine Market Share of Top 5 Manufacturers
Table United States Pneumococcal Infections Vaccine Sales by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales Share by Type (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Market Share by Type in 2015
Table United States Pneumococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pneumococcal Infections Vaccine by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Price by Type (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales by Application (2011-2016)
Table United States Pneumococcal Infections Vaccine Sales Market Share by Application (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Market Share by Application in 2015
Table United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Pneumococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Pasteur Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Chengdu Institute of Biological Products Basic Information List
Table Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chengdu Institute of Biological Products Pneumococcal Infections Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Infections Vaccine
Figure Manufacturing Process Analysis of Pneumococcal Infections Vaccine
Figure Pneumococcal Infections Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Infections Vaccine Major Manufacturers in 2015
Table Major Buyers of Pneumococcal Infections Vaccine
Table Distributors/Traders List
Figure United States Pneumococcal Infections Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Pneumococcal Infections Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Pneumococcal Infections Vaccine Production Forecast by Type (2016-2021)
Table United States Pneumococcal Infections Vaccine Consumption Forecast by Application (2016-2021)